Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 2,387,228 |
|
|||||
| News | - | ||||||
| Day High | 0.2175 | Low High |
|||||
| Day Low | 0.1651 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.039 | 22.81% | 0.21 | 16:01:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.18 | 0.1651 | 0.2175 | 0.21 | 0.171 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 306 | 2,387,228 | $ 0.181591 | $ 433,498 | - | 0.1456 - 0.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:51 | formt | 119,047 | $ 0.21 | USD |
CytoDyn Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 195.54M | 921.12M | 556.02M | 0 | -79.82M | -0.09 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.184 | 0.2175 | 0.15 | 0.1649365 | 3,686,224 | 0.026 | 14.13% |
| 1 Month | 0.155 | 0.2175 | 0.15 | 0.1667623 | 1,816,885 | 0.055 | 35.48% |
| 3 Months | 0.215 | 0.23504 | 0.1456 | 0.171732 | 1,266,050 | -0.005 | -2.33% |
| 6 Months | 0.2617 | 0.3103 | 0.1456 | 0.2071745 | 1,461,908 | -0.0517 | -19.76% |
| 1 Year | 0.36 | 0.48 | 0.1456 | 0.2522185 | 1,650,962 | -0.15 | -41.67% |
| 3 Years | 2.68 | 7.70 | 0.1456 | 1.75 | 2,485,645 | -2.47 | -92.16% |
| 5 Years | 0.58 | 10.01 | 0.0552 | 2.32 | 2,680,098 | -0.37 | -63.79% |
CytoDyn (QB) Description
| CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. |
